Show Summary Details
Page of

Amyloidosis: Immunopathogenesis and diagnosis 

Amyloidosis: Immunopathogenesis and diagnosis
Amyloidosis: Immunopathogenesis and diagnosis

H.J. Lachmann

and P.N. Hawkins

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 August 2020

Amyloidosis is a disorder of protein folding in which normally soluble plasma proteins are deposited in the extracellular space in an abnormal insoluble fibrillar form. Accumulation of these fibrils causes progressive disruption of the structure and function of any body tissue or organ. Without treatment systemic disease is usually fatal, but measures that reduce the supply of amyloid fibril precursor proteins can frequently lead to regression of amyloid deposits, prevention of organ failure and improved survival. However, as the regression of amyloid is relatively slow, early diagnosis greatly improves the prognosis. Amyloid is remarkably diverse and can be hereditary or acquired, localized or systemic, and lethal or merely an incidental finding. It is rare but not especially so, with systemic amyloidosis being responsible for about one in 1500 deaths in the UK.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.